Refine by
Vaccine Trials Articles & Analysis
20 articles found
In recent years, many peptide vaccines targeting viruses (such as HIV, hepatitis B, SARS-CoV-2), bacteria (such as Mycobacterium tuberculosis), and tumor antigens (such as MAGE-A1, HER2) are in clinical trial stages, some advancing to late-stage research, showing broad application prospects. ...
In a significant stride towards eradicating a debilitating disease, a new polio vaccine has achieved WHO prequalification. This development represents a crucial milestone in global health, where effective vaccination remains our strongest defence. ...
MADISON, Wis., Sept. 7, 2022 /PRNewswire/ — FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the completion of enrollment of the first cohort in an age de-escalation clinical trial of M2SR (M2 Deficient Single Replication) live virus vaccine, ...
Results will inform protocol design of Phase 1/2 clinical trial of Company's lead HSV-2 therapeutic vaccine candidate WOBURN, Mass. and OXFORD, England, Aug. 15, 2022 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the launch of a clinical ...
NLS) have provided the following observations: Mice vaccinated with HSV-2 0?NLS showed an improved antibody response compared to vaccination with a subunit vaccine candidate, Mice immunized with HSV-2 ...
Although vaccines against COVID-19 are unlikely to eradicate the disease in the way that the smallpox vaccine did, they have proved very effective in preventing death and hospitalisation, with enormous societal and economic benefits. There is now considerable research effort invested in building on the success of prophylactic vaccines in ...
People infected with either of these diseases have a 50% to 100% chance of dying. There is already a vaccine approved for use on horses and a modified vaccine has entered human clinical trials. ...
The study, called the Vaccination Against Canine Cancer Study, or VACCS, is the largest, most expensive interventional veterinary cancer trial to date. ...
ByCalviri
Carlos Fierro, Chief Medical Officer at Johnson County Clinical Trials, and Principal Investigator of the FluGen H3N2 v0005 clinical trial. ...
In the past few days, Moderna and Pfizer have released some promising clinical trials of their Covid-19 vaccinations. While these are still in the trial phase, many remain hopeful that the end of this deadly pandemic is near. ...
On November 9, 2020, Pfizer and BioNTech announced that their trial of a Covid-19 vaccine showed a 90% efficacy rate and very promising results in participants who had developed symptoms. ...
“The concept of self-medication isn’t going away, even after the pandemic ends: we’ve learned to adapt to telemedicine, and the self-administration of therapeutics and vaccines isn’t far behind,” Mr. Damon contends. Micron has completed a Phase 1 clinical trial of a seasonal influenza vaccine based on its ...
A gold rush is on to find a vaccine for COVID-19. According to the World Health Association (WHO) in early May, there are more than 100 projects around the world centered on the development of a vaccine for the coronavirus. Eight candidate vaccines are already being tested in people in clinical trials. Once an effective ...
CoroFlu could be in human clinical trials by the fall of 2020. Four Phase I and Phase II clinical trials involving hundreds of subjects have shown the M2SR flu vaccine to be safe and well tolerated. ...
With researchers ramping up efforts to develop a COVID-19 vaccine, progress has been achieved at unprecedented speed. In just two months, the first vaccine candidate entered clinical trials. ...
However, these designs are poorly applicable for the development of cancer therapeutic vaccines because the expected safety concerns for these vaccines are not as much as cytotoxic agents. The primary objectives of a cancer therapeutic vaccine phase I trial thus often include determining whether the vaccine shows ...
The clinical trial Mel participated in was the first live-attenuated herpes vaccine tested on humans. ...
Two earlier reported studies indicated the beneficial clinical effects of THIVAC, a therapeutic HIV vaccine derived from the blood of HIV-positive donors. However, in those studies no stringent statistical analysis to support the beneficial clinical outcome was attempted. ...
India has more than 5 million people infected with HIV-1 and this number is likely to increase in coming years. It is estimated that by the turn of this decade more than 10 million people would have been infected with this virus. More than 90% of these infections are due to subtype C. Therefore, it is imperative that a vaccine be developed based on local circulating subtype and tested for ...
This purified vaccine was tested in the clinical phase I/II trial in healthy non-infected adults in China. About 518 volunteers in Southern region and 650 volunteers from the Northern region of China were vaccinated. Volunteers then received one or two boosts at two weeks post-vaccination. ...